← Back to Nuqta Atlas
Editorially curated · qa-covid19-biorepository
Qatar COVID-19 Biorepository
Two-arm national biorepository collecting samples and health information for disease-course and vaccine research.
01 / Project overview
What the record establishes.
- Geographic scope
- National
- Project type
- infectious-disease biorepository and cohort
- Research domain
- COVID-19 host genomics, immunology, and public health
- Years
- 2020–
- Lifecycle status
- closed to new recruitment; repository retained
- Status basis
- QPHI's current page states that the national study was established at the start of the pandemic and is not currently admitting new participants.
- Status evidence date
- 2026-08-15
- Scale
- Target 6,000 participants across disease and vaccination arms; final enrollment not publicly confirmed on the current page.
02 / Organizations and population
Who and what the project connects.
- Lead organizations
- Qatar Biobank · Qatar Precision Health Institute
- Partner organizations
- Ministry of Public Health · Hamad Medical Corporation · Primary Health Care Corporation
- Organism / population
- People with laboratory-confirmed COVID-19 and COVID-19 vaccine recipients
03 / Data and access
What exists and how it can be reached.
Data types
- biospecimens
- clinical data
- host genomic data
- immune data
- vaccine data
Data access
Controlled research access; registry metadata are public.
Identifiers
No public accession or identifier is listed for this record.
04 / Evidence and provenance
Why the record is included.
Inclusion basis
National reusable pandemic biorepository with a defined target and explicit disease/vaccine arms.
Editorial note
Participant resource may support genomic studies but public pages do not quantify how many received WGS.
Sources
- primary record source Verified 2026-08-15
- additional record source Verified 2026-08-15
Release v0.2.0